STATE STREET CORP - SUNESIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$15,0000.0%27,8510.0%0.00%
Q1 2016$15,000
-40.0%
27,8510.0%0.00%
Q4 2015$25,000
+8.7%
27,8510.0%0.00%
Q3 2015$23,000
-74.2%
27,851
-6.0%
0.00%
Q2 2015$89,000
-95.1%
29,622
-96.0%
0.00%
Q1 2015$1,806,000
+9.9%
736,648
+14.4%
0.00%
Q4 2014$1,643,000
-57.9%
644,126
+17.8%
0.00%
Q3 2014$3,902,000
+23.6%
546,682
+12.8%
0.00%
Q2 2014$3,158,000
+11.7%
484,762
+13.4%
0.00%
Q1 2014$2,826,000
-26.3%
427,307
-50.1%
0.00%
Q4 2013$3,832,000
+76.2%
856,045
+95.3%
0.00%
Q3 2013$2,175,000
-2.0%
438,390
+2.9%
0.00%
Q2 2013$2,219,000426,0690.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 8,250,000$7,404,0003.11%
BVF INC/IL 4,777,381$4,288,0000.73%
NEA Management Company, LLC 7,789,644$7,011,0000.45%
Palo Alto Investors LP 6,974,854$6,260,0000.35%
Healthcare Value Capital, LLC 150,000$135,0000.22%
Frontier Wealth Management LLC 527,870$474,0000.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,067,122$1,855,0000.06%
Baker Brothers Advisors 4,450,000$3,994,0000.03%
Noven Financial Group, Inc. 41,000$37,0000.03%
FRANKLIN STREET ADVISORS INC /NC 100,000$90,0000.02%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders